2025 HCPCS code J2430
Effective Date: N/A Drugs Administered Other than Oral Method - Drugs, Administered by Injection Feed
Injection, pamidronate disodium, 30 mg
Modifiers may apply. Refer to specific payer guidelines for appropriate modifier usage in conjunction with J2430.
Medical necessity is established by the underlying diagnosis for which the pamidronate is being administered. Documentation must support the diagnosis and the need for treatment.
The provider uses pamidronate disodium to manage high calcium levels in patients due to cancer. It's also used to treat Paget’s disease of bone and bone damage resulting from certain types of cancer. This code represents the supply of the drug, not the administration.
In simple words: This code is for a 30mg injection of pamidronate, a medicine used to treat high calcium levels in the blood, often caused by cancer. It's a type of drug that helps strengthen bones.
Pamidronate disodium belongs to a class of drugs known as bisphosphonates that a provider uses to treat high levels of calcium in the blood related to other diseases. One unit of this code represents 30 mg of pamidronate disodium. Routes of administration include intravenous.
Example 1: A patient with multiple myeloma experiencing hypercalcemia receives a 30mg injection of pamidronate disodium to lower their calcium levels., A patient with breast cancer metastatic to bone receives pamidronate disodium to reduce the risk of skeletal-related events like fractures., A patient with Paget's disease of the bone receives pamidronate disodium to help manage bone pain and reduce the rate of bone turnover.
Documentation should include the diagnosis necessitating the medication (e.g., hypercalcemia of malignancy, Paget's disease), the dosage administered (30mg), and the route of administration (intravenous).
** This is a generic drug. Brand names for this drug include Aredia®. This code represents the supply of the drug. Check coding and individual payer guidelines to determine whether you can also report the administration of the drug separately.
- Specialties:Medical Oncology, Hematology, Endocrinology, Orthopedic Oncology
- Place of Service:Office, Inpatient Hospital, Outpatient Hospital, Independent Clinic, and other places authorized for intravenous injections.